ZTS Q2 2022 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

Q2 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.1B+5.3% YoY

Gross Profit

$1.4B67.7% margin

Operating Income

$726M35.4% margin

Net Income

$529M25.8% margin

EPS (Diluted)

$1.12

QoQ Revenue Growth

+3.3%

Cash Flow

Operating Cash Flow

$336M

Free Cash Flow

$190M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$13.8B

Total Liabilities

$9.2B

Stockholders' Equity

$4.6B

Cash & Equivalents

$2.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.1B	$1.9B	+5.3%
Gross Profit	$1.4B	$1.3B	+3.8%
Operating Income	$726M	$724M	+0.3%
Net Income	$529M	$512M	+3.3%

Revenue Segments

Dogs and Cats

$1.3B65%

Cattle

$328M16%

Swine

$144M7%

Poultry

$121M6%

Horses

$63M3%

Fish

$47M2%

Geographic Segments

United States Segment

$1.1B54%

International Segment

$943M46%